Are Lung Ultrasound Findings in COVID-19 Pneumonia Typical or Specific?

Praxis ◽  
2021 ◽  
Vol 110 (8) ◽  
pp. 421-425
Author(s):  
Giovanni Volpicelli ◽  
Luciano Cardinale ◽  
Thomas Fraccalini

Abstract. The application of point-of-care lung ultrasound (LUS) in the first diagnosis and management of Corona Virus Disease 2019 (COVID-19) has gained a great interest during a pandemic that is undermining even the most advanced health systems. LUS demonstrated high sensitivity in the visualization of the interstitial signs of the typical pneumonia complicating the infection. However, although this disease gives typical lung alterations, the same LUS signs observed in COVID-19 pneumonia can be detected in other common pulmonary conditions. While being non-specific when considered separately, the analysis of the distribution of the sonographic typical signs allows the assignment of 4 LUS patterns of probability for COVID-19 pneumonia when the whole chest is examined and attention is paid to the presence of other atypical signs. Moreover, the combination of LUS likelihood with the clinical phenotype at presentation increases the accuracy. This mini-review will analyze the LUS signs of COVID-19 pneumonia and how they can be combined in patterns of probability in the first approach to suspected cases.

Author(s):  
Mustafa J. Musa ◽  
Mohamed Yousef ◽  
Mohammed Adam ◽  
Awadalla Wagealla ◽  
Lubna Boshara ◽  
...  

: Lung ultrasound [LUS] has evolved considerably over the last years. The aim of the current review is to conduct a systematic review reported from a number of studies to show the usefulness of [LUS] and point of care ultrasound for diagnosing COVID-19. A systematic search of electronic data was conducted including the national library of medicine, and the national institute of medicine, PubMed Central [PMC] to identify the articles depended on [LUS] to monitor COVID-19. This review highlights the ultrasound findings reported in articles before the pandemic [11], clinical articles before COVID-19 [14], review studies during the pandemic [27], clinical cases during the pandemic [5] and other varying aims articles. The reviewed studies revealed that ultrasound findings can be used to help in the detection and staging of the disease. The common patterns observed included irregular and thickened A-lines, multiple B-lines ranging from focal to diffuse interstitial consolidation, and pleural effusion. Sub-plural consolidation is found to be associated with the progression of the disease and its complications. Pneumothorax was not recorded for COVID-19 patients. Further improvement in the diagnostic performance of [LUS] for COVID-19 patients can be achieved by using elastography, contrast-enhanced ultrasound, and power Doppler imaging.


Praxis ◽  
2020 ◽  
Vol 109 (8) ◽  
pp. 583-591 ◽  
Author(s):  
Joseph Osterwalder

Zusammenfassung. Für ein optimales Management der COVID-19 (Coronary Virus Disease 19) sind wir auf eine schnelle und zuverlässige Diagnose sowie Schweregradeinschätzung angewiesen. Der Goldstandard ist bisher die RT-PCR (Reverse-Transkriptase-Polymerase-Kettenreaktion) aus dem nasopharyngealen Abstrich. Die aktuellen Tests weisen eine Sensitivität zwischen 60 und 90 % auf. In der Folge müssen wir mit 10–40 % falsch-negativen Ergebnissen rechnen. Neben der Sauerstoffsättigung zur Schweregradeinteilung werden das Stethoskop, das Thoraxröntgen und die Lungen-Computertomografie routinemässig für die Diagnose eingesetzt. Die Standardmethoden Stethoskop und Thoraxröntgen sind jedoch unzuverlässig. Überdies setzen alle drei diagnostischen Untersuchungsverfahren Ärztinnen, Ärzte, Hilfspersonal sowie Patientinnen und Patienten einem zusätzlichen Expositionsrisiko aus. Angesichts der Kontagiosität des SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus) ist der Lungen-Point-of-Care-Ultraschall (PoCUS), insbesondere in der Anwendung als Taschenkittelgerät, eine noch zu wenig genutzte, wertvolle Alternative. In dieser Review werden die aktuelle Wertigkeit und Rolle von Stethoskop, Pulsoximetrie, Thoraxröntgen, Lungen-Computertomografie und Lungen-Point-of-Care-Ultraschall anhand der vorliegenden Literatur bestimmt.


2020 ◽  
Vol 38 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Cynthia A. Gravel ◽  
Michael C. Monuteaux ◽  
Jason A. Levy ◽  
Andrew F. Miller ◽  
Rebecca L. Vieira ◽  
...  

2020 ◽  
Author(s):  
Luis Fernando L Paredes ◽  
Ivan I Ilescas

In late December 2019, a new disease reported at the time by an unknown pathogen was reported, which was later found to be a new variant of coronavirus, now called SARS-CoV2. This new disease had a very rapid global spread, causing multiple deaths in a short time, and which led to putting the entire world on health alert. In patients who have this disease, they present bilateral opacities in frosted multilobar glass with peripheral distribution. Some authors have suggested the use of ultrasound at the point of care for its early recognition. In this study, we evaluated the findings of lung ultrasound in 25 patients admitted to the General Hospital Dr. Enrique Cabrera, Mexico, with a diagnosis confirmed by RT-PCR of SARS CoV2. This small retrospective study suggests that artifacts like glass rockets with or without the Birolleau variant (White lung), confluent B-lines, thick irregular pleural lines, and variable size (subpleural) consolidations are typical findings of lung ultrasound in patients with COVID-19 pneumonia. The presence of these findings is useful when evaluating patients with suspected COVID-19. In resource-limited and austere settings where chest radiography, CT, and RT-PCR are not available or the response time is long, lung ultrasound performed by trained personnel can be an aid in the diagnosis of COVID-19.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Thomas Lee ◽  
Bradley Goldberg ◽  
Kathryn Pade ◽  
Atim Uya ◽  
Stephanie Cohen ◽  
...  

Author(s):  
Nathalie Gil ◽  
Jenny Heneriz ◽  
Dennis Diaz ◽  
Mike Tomas ◽  
Gualberto Ruaño ◽  
...  

A case series of 22 patients with confirmed SARS-CoV-2 infection and Corona Virus Disease 2019 (COVID-19) symptoms was followed in a primary care clinic. We provided quantitative and longitudinal profiling for SARS-CoV-2 IgM and IgG with a point of care device. Half the patients had a history of anosmia or ageusia. IgM and IgG responses were highly heterogeneous quantitatively and temporally. We determined that clinical symptomatology of chemosensory loss correlated with lesser but sustained titers of IgM and IgG whereas normal chemosensation correlated with transiently higher but rapidly declining antibody levels.


2020 ◽  
Vol 12 (3) ◽  
pp. 49-56
Author(s):  
Septian Adi Permana ◽  
Adhrie Sugiarto ◽  
Muhammad Husni Thamrin ◽  
Purwoko Purwoko ◽  
Arifin Arifin ◽  
...  

Latar belakang: Ko-infeksi jamur pada pasien Corona Virus Disease 2019 (COVID-19) acapkali terjadi. Hal itu dikarenakan kegagalan sistem imun karena infeksi COVID-19 maupun karena pengobatan anti inflamasi yang diberikan.Kasus: Seorang laki-laki 39 tahun dengan acute respiratory distress syndrome (ARDS) berat akibat infeksi COVID-19 dan disertai dengan ko-infeksi jamur. Pasien ini mendapatkan pengobatan steroid dari awal masuk dan pada hari ke-6 hasil kultur sputumnya menunjukkan adanya ko-infeksi jamur. Pasien ini memiliki komorbid berupa riwayat diabetes mellitus. Dari pemeriksaan fisik ditemukan dispnea, takipnea, takikardia sejak hari pertama. Dari hasil laboratorium menunjukkan angka leukosit, high sensitivity c-reactive protein (HsCRP), serum glutamic oxaloacetic (SGOT), gula darah, d-dimmer, lactat dehydrogenase (LDH) dan limfosit netrophyl ratio (LNR) yang tinggi. Pada pasien ini didapatkan rasio PaO2 / FiO2 rendah dan procalcitonin (PCT) yang normal. Dari kultur sputum ditemukan adanya infeksi jamur dan dari hasil rontgen toraks (CXR) menunjukkan pneumonia bilateral. Pasien ini dirawat dengan terapi standar dan mendapatkan dexametason 5 mg / 8 jam, setelah kultur sputum menunjukkan infeksi jamur, pasien juga mendapat mycafungin untuk pengobatan jamurnya.Diskusi: Kecurigaan terhadap ko-infeksi jamur pada pasien COVID-19 yang mendapatkan terapi steroid dalam jangka waktu lama maupun adanya penyerta diabetes harus dipikirkan. Penggunaan terapi anti jamur empiris pun acapkali diperlukan untuk mengurangi morbiditas dan mortalitas.Kesimpulan: Infeksi COVID-19 memiliki risiko terjadinya ko-infeksi, salah satunya adalah infeksi jamur. Insiden koinfeksi jamur diperberat dengan pemberian pengobatan steroid dan riwayat diabetes mellitus. 


Sign in / Sign up

Export Citation Format

Share Document